Schwartz–Jampel syndrome is not related to malignant hyperthermia

Schwartz–Jampel syndrome (SJS) is a rare syndrome that is clinically characterized by myotonia and skeletal abnormalities. Most reports regarding SJS have stated that patients with SJS are susceptible to malignant hyperthermia (MH). The statement is incorrect. There is no report showing that SJS is...

Descripción completa

Detalles Bibliográficos
Autor principal: Godai, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804619/
https://www.ncbi.nlm.nih.gov/pubmed/29457076
http://dx.doi.org/10.1186/s40981-017-0104-7
_version_ 1783298877301981184
author Godai, Kohei
author_facet Godai, Kohei
author_sort Godai, Kohei
collection PubMed
description Schwartz–Jampel syndrome (SJS) is a rare syndrome that is clinically characterized by myotonia and skeletal abnormalities. Most reports regarding SJS have stated that patients with SJS are susceptible to malignant hyperthermia (MH). The statement is incorrect. There is no report showing that SJS is related to MH. Scientific evidence also shows that patients with myotonias are not susceptible to MH except for that with hypokalemic periodic paralysis. Medical practitioners must recognize that SJS is not related to MH.
format Online
Article
Text
id pubmed-5804619
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58046192018-02-14 Schwartz–Jampel syndrome is not related to malignant hyperthermia Godai, Kohei JA Clin Rep Letter to the Editor Schwartz–Jampel syndrome (SJS) is a rare syndrome that is clinically characterized by myotonia and skeletal abnormalities. Most reports regarding SJS have stated that patients with SJS are susceptible to malignant hyperthermia (MH). The statement is incorrect. There is no report showing that SJS is related to MH. Scientific evidence also shows that patients with myotonias are not susceptible to MH except for that with hypokalemic periodic paralysis. Medical practitioners must recognize that SJS is not related to MH. Springer Berlin Heidelberg 2017-06-06 /pmc/articles/PMC5804619/ /pubmed/29457076 http://dx.doi.org/10.1186/s40981-017-0104-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Godai, Kohei
Schwartz–Jampel syndrome is not related to malignant hyperthermia
title Schwartz–Jampel syndrome is not related to malignant hyperthermia
title_full Schwartz–Jampel syndrome is not related to malignant hyperthermia
title_fullStr Schwartz–Jampel syndrome is not related to malignant hyperthermia
title_full_unstemmed Schwartz–Jampel syndrome is not related to malignant hyperthermia
title_short Schwartz–Jampel syndrome is not related to malignant hyperthermia
title_sort schwartz–jampel syndrome is not related to malignant hyperthermia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804619/
https://www.ncbi.nlm.nih.gov/pubmed/29457076
http://dx.doi.org/10.1186/s40981-017-0104-7
work_keys_str_mv AT godaikohei schwartzjampelsyndromeisnotrelatedtomalignanthyperthermia

Ejemplares similares